Latest Conference Articles

At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.

Single-use packaging and excess sample distribution contribute to environmental harm, necessitating a shift in industry practices.

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of March.

At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a female patient aged 12 years with moderate AD that had been worsening over the past several months.

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a woman aged 25 years who presented with erythematous and scaly patches on her face, neck, and upper trunk.

Click through our slideshow to see a glimpse of what the 2025 Masterclasses in Dermatology conference has to offer.

Are you attending Winter Clinical Hawaii? Answer our poll below to let us know.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a woman aged 27 years who had eczematous lesions covering more than 20% of her BSA.

Catch up on coverage from the 2025 South Beach Symposium held in Miami Beach, Florida.

Lio emphasizes that patient comfort and understanding are essential for successful treatment outcomes.

Many patients, especially parents of pediatric patients, exhibit steroid phobia, impacting treatment adherence.

Swanson shared strategies for treating rural dermatology patients at MOPD 2025, emphasizing effective initial care, the role of telehealth, and practical treatments.

Long-term safety data suggests that JAK inhibitors have a lower risk of cardiovascular and thromboembolic events than previously thought.

Medical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.

Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.

Catch up on coverage from the third day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Advances in biologics, JAK inhibitors, and PDE4 inhibitors provide personalized options for psoriasis management.

Compliance with acne medications remains a challenge, but timely intervention can prevent severe skin damage.

Mona Shahriari, MD, FAAD advocates for improving diversity in clinical imagery and trials to enhance trust in patients with skin of color.

Many patients with severe AD are unaware of newer, more effective treatments.

A holistic yet time-efficient approach can help dermatologists recognize early joint pain symptoms associated with psoriasis.

A balanced approach to dermatologic care involves using steroids for flare-ups and switching to non-steroidal options for maintenance.

Chilukuri said devices should be user-friendly even in solo practice settings to maximize efficiency and usability.

Catch up on coverage from the second day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Michael Gold, MD, explored medical and procedural acne treatments and the emerging role of exosomes in regenerative dermatology.

Traditional descriptions often cater to lighter skin, necessitating updates to better serve diverse populations.